Suppr超能文献

覆膜支架腔内修复术后应用高径向力支架预防或治疗肢体闭塞的结果。

Results of adjunctive stenting with high-radial force stents to prevent or treat limb occlusion after EVAR.

机构信息

Unit of Vascular and Endovascular Surgery, San Giovanni Addolorata Hospital, Rome, Italy -

Unit of Vascular and Endovascular Surgery, Santa Maria della Misericordia Hospital, University of Perugia, Perugia, Italy.

出版信息

J Cardiovasc Surg (Torino). 2021 Jun;62(3):250-257. doi: 10.23736/S0021-9509.21.11635-0. Epub 2021 Feb 26.

Abstract

BACKGROUND

The aim of this study was to report the results of a multicenter experience on the use of adjunctive stents deployed inside abdominal aortic endografts with the purpose to prevent or treat limb occlusion after endovascular aneurysm repair (EVAR).

METHODS

Between 2010 and 2018, there were 35 patients with aorto-iliac aneurysm presenting one or more risk factors for endograft limb occlusion (narrow aortic bifurcation and/or stenotic, highly angulated or occluded iliac arteries), who were treated with standard bifurcated stent graft reinforced by the means of a single model of balloon-expandable platinum/iridium bare stent (CP Stent; NuMED, Inc., Hopkinton, NY, USA). Technical success, mortality, limb patency and reintervention rate during follow-up were the main endpoints assessed.

RESULTS

Technical success was 100%. No patients died perioperatively and no major complication was registered. During a mean follow-up of 48 months (range 1-87), neither aortic-related death nor secondary intervention was registered. At a mean follow-up imaging of 39.4 months (range 1-81) no endograft limb lost its patency.

CONCLUSIONS

The use of high-radial force balloon-expandable stents deployed inside bifurcated endografts to prevent or treat limb occlusion is a safe and effective adjunctive procedure, with outstanding long-term outcomes in terms of patency and reinterventions.

摘要

背景

本研究旨在报告多中心使用腹主动脉内支架治疗血管内动脉瘤修复(EVAR)后肢体闭塞的经验结果。

方法

2010 年至 2018 年,有 35 例患有主动脉-髂动脉瘤的患者存在一种或多种内支架移植物肢体闭塞的风险因素(主动脉分叉狭窄和/或狭窄、高度成角或闭塞的髂动脉),这些患者采用标准分叉支架移植物进行治疗,并采用单一型号的球囊扩张铂/铱裸支架(CP 支架;NuMED,Inc.,Hopkinton,NY,USA)进行加固。主要评估终点包括技术成功率、死亡率、肢体通畅率和随访期间的再干预率。

结果

技术成功率为 100%。无患者围手术期死亡,无重大并发症发生。平均随访 48 个月(范围 1-87)期间,未发生与主动脉相关的死亡或二次干预。平均随访影像学检查 39.4 个月(范围 1-81)时,无内支架移植物肢体闭塞。

结论

在分叉内支架移植物内放置高径向力球囊扩张支架以预防或治疗肢体闭塞是一种安全有效的辅助治疗方法,在通畅率和再干预方面具有出色的长期结果。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验